The latest happenings of the past month, all in one place.
MMS announced the growth of its leadership team with the appointment of Kelly J. Hill to Executive Vice President of Global Business Operations and Strategy, and Michelle Gayari to Executive Vice President of Global Operational Excellence and Innovation. The company also announced that Arunima Sen, MD, Director of Pharmacovigilance and Medical Writing (India), has been appointed to the Indian Society of Clinical Research’s Pharmacovigilance Council.
CTMA has appointed Arnaud Marcel as the new Chief Technology Officer.
Calyx announced that Craig M. Mooney joined the company as Vice President of Science and e-Tech Enabled Services.
PHASTAR announced the appointment of Chuck Gelb as Chief Commercial Officer.
Steve Rosenberg has joined uMotif's Board of Directors.
Imaging Endpoints announced that it has established a new office located in the Vorstaedte District of Basel, Switzerland.
THREAD has been awarded Frost & Sullivan’s 2021 Customer Value Leadership Award. Additionally the company has announced that worldwide analyst Everest Group has deemed them a Leader in the DCT sector.
Sensyne Health plc has reached a milestone of access to a combined clinical research, clinical trial, and real world de-identified and anonymized dataset of over 60 million patients.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.